Abizer Gaslightwala
CEO, Director · Akari Therapeutics Plc
IndividualBuying only
- 2024
- Oct 1, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Abizer Gaslightwala files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Hoyoung Huh - $1.50M in AKTX purchases and sales in the last 12 months
- Raymond Prudo-Chlebosz - $406K in AKTX purchases and sales in the last 12 months
- Samir Rashmikant Patel - $344K in AKTX purchases and sales in the last 12 months
- Sandip I. Patel - $162K in AKTX purchases and sales in the last 12 months
- Robert B. Bazemore - $62K in AKTX purchases and sales in the last 12 months
- Kameel D. Farag - $10K in AKTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Abizer Gaslightwala?
Abizer Gaslightwala is a corporate insider, tracked as CEO, Director of Akari Therapeutics Plc (AKTX). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Abizer Gaslightwala submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Abizer Gaslightwala been buying or selling stock?
Recorded transactions: 7 open-market purchases ($457K) and 0 open-market sales across all tracked filings.
